From 1993 to 2018, Prof. Tian Xu served as an assistant professor, associate professor, tenured professor, CNH Long Chair Professor, associate dean of the Department of Genetics and Neurobiology and advisor to President at Yale University. From 1996 to 2018, Prof. Xu served as adjunct professor at Fudan University, Chair Professor of the Yangtze River, Director of the Institute of Developmental Biology, and Director of the International Cooperation Research Centre for National Development and Disease. Prof. Xu has been a long-term editorial board member of the magazines, Annual Review of Genetics, Molecular Cancer Research, Integrative Biology, The International Journal of Biological Sciences, and the editorial board of Disease Models and Mechanisms. He has served as chairman of Chinese Association of Biologists. He was awarded the American Outstanding Postdoctoral Award (Whitney), American Outstanding Young Scientists Scholar (Pew), Howard Hughes Fellow, Tuberculosis Sclerosis Association Innovation Award and Outstanding Contribution Award, and the American Association for the Advancement of Science (AAAS Fellow) and other awards. Prof. Xu is not only the founder of LAM, Drug Farm, Double Rainbow, Fosun Lead, GeCell and other technology companies, but also an advisor of companies such as CuraGen, Butterfly, Hyperfine, Quantum-Si, etc.